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Quercetin is a potent anti-inﬂammatory ﬂavonoid, but its capacity to modulate insulin sensitivity in
obese insulin resistant conditions is unknown. This study investigated the effect of quercetin treatment
upon insulin sensitivity of ob/ob mice and its potential molecular mechanisms. Obese ob/ob mice were
treated with quercetin for 10 weeks, and L6 myotubes were treated with either palmitate or tumor
necrosis factor-a (TNFa) plus quercetin. Cells and muscles were processed for analysis of glucose
transporter 4 (GLUT4), TNFa and inducible nitric oxide synthase (iNOS) expression, and c-Jun
N-terminal kinase (JNK) and inhibitor of nuclear factor-kB (NF-kB) kinase (IkK) phosphorylation.
Myotubes were assayed for glucose uptake and NF-kB translocation. Chromatin immunoprecipitation
assessed NF-kB binding to GLUT4 promoter. Quercetin treatment improved whole body insulin
sensitivity by increasing GLUT4 expression and decreasing JNK phosphorylation, and TNFa and iNOS
expression in skeletal muscle. Quercetin suppressed palmitate-induced upregulation of TNFa and iNOS
and restored normal levels of GLUT4 in myotubes. In parallel, quercetin suppressed TNFa-induced
reduction of glucose uptake in myotubes. Nuclear accumulation of NF-kB in myotubes and binding of
NF-kB to GLUT4 promoter in muscles of ob/ob mice were also reduced by quercetin. We demonstrated
that quercetin decreased the inﬂammatory status in skeletal muscle of obese mice and in L6 myotubes.
This effect was followed by increased muscle GLUT4, with parallel improvement of insulin sensitivity.
These results point out quercetin as a putative strategy to manage inﬂammatory-related insulin
resistance.
& 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Insulin resistance is closely related to the pathogenesis of type
2 diabetes mellitus (DeFronzo, 2004). Several experimental stu-
dies show that an inﬂammatory response contributes to insulin
resistance in animal models of obesity (Chiang et al., 2009;
Hirosumi et al., 2002; Uysal et al., 1997). This inﬂammatory
response is elicited by cytokines such as tumor necrosis
factor-a(TNFa) or by saturated fatty acids (Ferna´ndez-Real and
Ricart, 2002; Groop et al., 1991; Katsuki et al., 1998). It is
important to note that under insulin resistance, the adipose tissue
and the skeletal muscles are important sources of TNFa (Borge
et al., 2009; Borst and Conover, 2005; Furuya et al., 2010), which: þ55 19 32892968.
eˆ).
lsevier OA license.ultimately impairs insulin action (Plomgaard et al., 2005; Thrush
et al., 2008).
Several intracellular pathways have been shown to disrupt
insulin signal transmission leading to insulin resistance. Both
saturated fatty acids (i.e.: palmitate) and TNFa can activate the
inhibitor of nuclear factor-kB kinase (IkK), the c-Jun N-terminal
kinase (JNK) (Senn, 2006; Tilg and Moschen, 2008) and the serine/
threonine kinases that phosphorylate the insulin receptor sub-
strate 1 (IRS1) and can impair insulin-stimulated serine/threonine
kinase (AKT) activation and glucose transporter 4 (GLUT4) trans-
location (Taniguchi et al., 2006). IkK may also activate transcrip-
tion factors that belong to the nuclear factor-kB (NF-kB) family,
thus inhibiting GLUT4 gene transcription (Furuya et al., 2010;
Ruan et al., 2002).
Quercetin is an abundant ﬂavonoid (Crozier et al., 1997) with a
well-recognized potent and non-selective anti-inﬂammatory
action that relies on a wide range of mechanisms of action.
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inducible nitric oxide synthase (iNOS) expression (Dias et al.,
2005) and lipoxygenase activity (Hu et al., 2006). It has been
demonstrated that quercetin administration diminishes hypergly-
cemia in rats rendered diabetic by streptozotocin injection (Vessal
et al. 2003). However, quercetin action is known to protect
pancreatic islets that certainly favors glycemic control in strepto-
zotocin-induced diabetes (Coskun et al., 2005; Kim et al., 2007).
In contrast to what was found in streptozotocin-induced
diabetes, the effects of quercetin in obese rodents have originated
controversial data. Addition of quercetin to high-fat diet did not
prevent obesity-induced insulin resistance in mice (Stewart et al.,
2009). However, intragastric quercetin improved whole body
insulin sensitivity and reduced iNOS expression in the liver of
obese rats (Rivera et al., 2008).
Considering the relevance of deﬁnitely determining whether
the natural compound quercetin has any effect upon insulin
resistance during the development of obesity, the present study
investigated the effects of quercetin on inﬂammatory status and
insulin sensitivity of ob/ob mice. The results showed that quer-
cetin reduced whole-body insulin resistance and decreased
inﬂammatory pathways in skeletal muscle. In addition, the
relationship between the anti-inﬂammatory property of querce-
tin, and its ability to improve insulin action in skeletal muscle was
further evidenced by in vitro experiments with L6 myotubes
challenged with palmitate and TNFa.2. Materials and methods
2.1. Animals and treatment
Recessive homozygote ob/ob mice aging approximately
3 months were obtained from the animal care facility of the
Federal University of Sao Paulo (CEDEME-UNIFESP) and the
experimental protocol was approved by the Ethical Committee
for Animal Research of the Institute of Biomedical Sciences of the
University of Sao Paulo. Animals (four per cage) had free access to
standard chow (Nuvilab CR-1; Nuvital, Curitiba, Brazil) and
water, and were maintained at 23 1C on a 12 h light/dark
cycle. Mice were divided into two groups that received either
quercetin or vehicle. Quercetin was suspended in distilled water
(15 mg/ml), and injected intraperitoneally (i.p.) every other day
for 10 weeks at the dosage of 30 mg/kg. Vehicle- and quercetin-
treated mice were killed at the end of the tenth week of
treatment, and respectively designated as CTL and Quer through-
out the manuscript.
2.2. Insulin tolerance test (ITT)
Insulin (2 U/kg) was administered i.p., and tail blood samples
were collected before and at 10, 20, 30, 40 and 60 min after
insulin injection for blood glucose determination. The rate con-
stant for glucose disappearance during insulin tolerance test (KITT)
was calculated using the formula 0.693/t1/2.
2.3. L6 cell culture and treatments
L6 myoblast were maintained in DMEM containing 10% Fetal
Bovine Serum (FBS), 25 mM glucose, penicillin (100 IU) and
streptomycin (100 mg/ml) in a humidiﬁed atmosphere with 5%
CO2 at 37 1C. L6 myoblasts (80% conﬂuent) were allowed to
differentiate into myotubes in DMEM containing 2% FBS for 4–6
days. Quercetin (diluted in ethanol) was added 48 h prior to the
experiments at a ﬁnal concentration ranging from 5 to 200 mM.
Palmitate treatment (750 mM) of myotubes was carried outduring the last 20 h of quercetin treatment in DMEM containing
1% Bovine Serum Albumin (BSA). TNFa treatment (20 ng/ml) was
carried out during the last 6 h of quercetin treatment. Acute
insulin challenge of myotubes (100 nM, 10 min.) was performed
in Krebs–Henseleit after a 45-min pre-incubation at 37 1C under a
95% O2:5%CO2 atmosphere. After stimulus, myotubes were
rapidly harvested in ice-cold PBS and pulled down to be processed
for further experiments.
2.4. Protein extraction and western blotting
Gastrocnemius muscles and myotubes were processed for
Western blotting as previously described (Anheˆ et al., 2007).
Membranes were probed with antibodies against phospho-IkK
(Cell Signaling Technology, Danvers, MA, USA), phospho-JNK,
phospho-AKT1/2/3 (Ser 473) (from Santa Cruz Biotechnology,
Santa Cruz, CA, USA) or b-actin (Millipore, Billerica, MA, USA).
Chemiluminescent detection was performed after incubation
with a secondary antibody conjugated to HRP (GE Healthcare,
Buckinghamshire, England). Band intensities were visualized in
X-ray sensitive ﬁlms and quantiﬁed by using Scion Image soft-
ware (Scioncorp, USA).
2.5. RNA isolation and RT-PCR
Total RNA was extracted from 100 mg of mice gastrocnemius
and L6 cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA).
cDNA was synthesized using InProm Reverse Transcriptase
(Promega, Madison, WI, USA). cDNA was used for end-point
conventional (GoTaq DNA Polymerase, Promega, Madison, WI,
USA) or real-time (SYBR Green master mix, Applied Biosystems,
Foster City, CA, USA) PCR. For the L6 samples end-point, PCR was
performed as already described (Bordin et al., 2004), and the
results were normalized by gapdh expression. For the muscle
samples, real-time PCR was performed, and the relative expres-
sion was analyzed using the 2(-Delta Delta C(T)) method (Livak &
Schmittgen, 2001). The primer sequences used, as well as anneal-
ing temperatures, are described in Supplementary tables 1 and
2 available as Supporting material.
2.6. Total membrane fractioning and GLUT4 detection
Cells and muscles were mixed with homogenization buffer and
processed as previously described (Anheˆ et al., 2007). Homoge-
nates were centrifuged at 700  g at 4 1C for 10 min. The pellets
containing protein from membrane fractions were obtained from
the supernatants (Anheˆ et al., 2007). The intensity of the bands
representing GLUT4 was quantiﬁed by densitometry and normal-
ized by the densitometric scanning of coomassie brilliant blue
(CBS) stained gel using the whole lane for each sample. After-
wards, taking into account the total protein yield from each
muscle the results were expressed as total GLUT4 (AU) per whole
tissue.
2.7. Nuclear translocation of NF-kB proteins
L6 myotubes were suspended in cell lysis buffer (10 mM Tris
pH 8.0, 10 mM NaCl, 0.2% Nonidet-P40) containing phosphatase
and protease inhibitors (sodium orthovanadate, phenylmethyl-
sulphonyl ﬂoride and aprotinine). After 10 min incubation on ice,
the samples were centrifuged at 2,500 xg for 15 min at 4 1C. The
pellets of nuclei were suspended in nuclear lysis buffer (20 mM
tris pH 8.0, 10 mM EDTA, 1% SDS and phosphatase and protease
inhibitors). Afterwards, the samples were homogenized by soni-
cation and processed as for Western blot. The nitrocellulose
membranes with nuclear proteins were probed with antibodies
G.F Anheˆ et al. / European Journal of Pharmacology 689 (2012) 285–293 287against c-Rel, p50 and p52 (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Chemiluminescent detection was performed as
described in Western blot section. Membranes were stained with
ponceau in order to check for equal protein loading in all
experiments.2.8. Chromatin Immunoprecipitation (ChIP) assay
Gastrocnemius muscles from ob/ob mice were processed using
buffers and reagents from EZ ChIP Chromatin Immunoprecipita-
tion Kit (Upstate, Lake Placid, NY, USA) according to the manu-
facturer instructions. Brieﬂy, muscles were removed and minced
in PBS containing 1% formaldehyde. Next, tissue fragments were
incubated for 10 min at room temperature and transferred to
Lysis Buffer. DNA was sheared to fragments of approximately
200–1000 bp by applying eight bursts of sonication (20% of
power, 10 s each). Samples were diluted in Dilution Buffer and
pre-cleared for 1 h at 4 1C with protein G-agarose (50% slurry) (GE
Healthcare, Buckinghamshire, England) saturated with salmon
sperm DNA. An aliquot of 10 ml was collected as ‘‘input’’. The
remaining supernatants were subjected to immunoprecipitation
with protein G-agarose saturated with salmon sperm DNA and
5 mg of anti-p50 NF-kB antibody (Santa Cruz Biotechnology,
sc-26418). In parallel, one sample was incubated with protein
G-agarose only in order to generate the negative control (no-
AB). Agarose pellets were then washed with buffers provided in
the kit and treated with elution buffer. Supernatants were sub-
jected to crosslinking reversal and RNase A treatment. DNA was
puriﬁed using phenol-chloroform and resuspended in 20 ml of
ddH2O. DNA samples were ampliﬁed for detection of Slc2a4
promoter. Primers spanning the GLUT4 50 region from 151 tobo
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Fig. 1. Intraperitoneal quercetin treatment increases insulin sensitivity in ob/ob mice. O
weeks. Mice were weighed weekly (A) and fasting glycemia was measured at the end of
from data acquired after intraperitoneal insulin tolerance test (C). Gastrocnemius musc
muscles were processed for total membrane fractioning and GLUT4 detection by Wester
blue stained (CBS) gel (E – lower panel) and expressed as total GLUT4 (AU) per whole tis
before the beginning of treatment with quercetin; @ Po0.05 vs. mice before the beginþ73 were 50–TTCCGTGGGTTGTGGCAGTG-30 and 50–ACCAGTG-
TTCCAGTCACTCGCTG-30. The products were ampliﬁed by real
time PCR, as described in the previous section, using 3.0 mM of
MgCl2, 2 ml of template DNA and 55 1C of annealing temperature.
The input values from each sample were used as inner control and
the 2(-Delta Delta C(T)) formula was used to calculate relative
binding of NF-kB p50 to GLUT4 promoter. After reaction, the
products were run on a 2% agarose gel and a digital image was
acquired.2.9. 2-Deoxy-[2,63H]D-glucose (DG) uptake
Myotubes seeded in six-well plates were treated as previously
described and pre-incubated for 6 h in DMEM without serum and
glucose. DMEM was removed and cells were washed and pre-
incubated with Krebs-Henseleit at 37 1C for 10 min with or without
insulin (100 nM). The buffer was replaced by a fresh one containing
5.6 mM glucose and 0.2 mCi/ml 2-DG, and cells were incubated for
20 min at 37 1C. Next, cells were washed in iced-cold PBS and the
radioactivity associated with the cells was determined after lysis
with 1 M KOH at 70 1C, followed by liquid scintillation of aliquots
(100 ml). The uptake measurement was performed in triplicate.
Protein concentration of each sample was determined by the
Bradford method. Results were normalized by mg of total protein.2.10. Data analysis
All values are mean7S.E.M.. Means from both cells and mice
experiments were statistically analyzed by unpaired Student’s
t-test or one-way ANOVA, with Newman–Keuls post-testK
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Fig. 2. Quercetin prevents downregulation of GLUT4 expression and insulin-induced glucose uptake elicited by palmitate but does not modulate Akt serine
phosphorylation. L6 myotubes were treated with 25 mM quercetin and/or 750 mM palmitate (Pal) as described in the section 2.3. After treatment, myotubes were
incubated in Krebs buffer and acutely (10 min.) stimulated with insulin (100 nM) or vehicle (NaCl 0.9%). Non-stimulated and insulin-stimulated L6 myotubes were
processed for 2-DG uptake assay (A) and Western blot detection of serine 473 phosphorylated Akt1/2/3, which was normalized to b actin (B). Myotubes treated with
quercetin (Q25) and/or palmitate (Pal) were also used for total membrane extraction and GLUT4 detection by Western blot (C). Data are presented as mean7S.E.M..
*Po0.05 vs. non insulin-stimulated myotubes within the same condition; # Po0.05 vs. insulin-stimulated CTL; & Po0.05 vs. non insulin-stimulated CTL; ## Po0.05 vs.
insulin-stimulated Pal; && Po0.05 vs. non insulin-stimulated Pal; @ Po0.05 vs. CTL (n¼5 for 2-DG uptake and phospho Akt and n¼6 for GLUT4).
G.F Anheˆ et al. / European Journal of Pharmacology 689 (2012) 285–293288(INStat - Graph Pad Software, Inc., San Diego, USA). The level of
signiﬁcance was set at Po0.05.3. Results
3.1. Quercetin treatment decreases fasting glycemia and insulin
resistance and increases GLUT4 expression in skeletal muscle in ob/ob
mice
Our ﬁrst experimental approach showed that quercetin treat-
ment did not affect body weight gain (Fig. 1A). However, querce-
tin reduced fasting glycemia to values close to 88% of those from
vehicle-treated ob/ob mice after 10-week treatment (Fig. 1B), and
that must have been the consequence of insulin sensitivity
increasing in ob/ob treated-mice, in such a way that KITT values
of Quer mice was 206% of those from CTL mice (Fig. 1C).
Fig. 1D shows that GLUT4 mRNA was upregulated in skeletal
muscle of ob/ob mice treated with quercetin (to 149% of CTL micevalues); and that was accompanied by a parallel increase of 154%
in GLUT4 protein content (Figs. 1E and F).
3.2. Downregulation of GLUT4 expression and insulin-induced
glucose uptake induced by palmitate are prevented by quercetin
without changes in AKT serine phosphorylation
Palmitate decreased 2-DG uptake in insulin stimulated (to 54%
of insulin-stimulated CTL values) and non stimulated L6 myo-
tubes (to 58% of non-stimulated CTL values). Quercetin (25 mM)
prevented this effect of palmitate (Fig. 2A). Non-stimulated and
insulin-stimulated glucose uptake in cells treated with quercetin
plus palmitate were, respectively, 162% and 145% of that from
cells treated with palmitate only. However, cells treated with
quercetin plus palmitate remained insulin resistant. Insulin-
stimulated AKT serine phosphorylation was also reduced by
palmitate treatment (to 30% of insulin stimulated-stimulated
CTL values) which was not recovered by quercetin (Fig. 2B).
GLUT4 protein content was reduced in cells treated with
G.F Anheˆ et al. / European Journal of Pharmacology 689 (2012) 285–293 289palmitate (to 54.8% of CTL values) but the addition of quercetin
prevented this downregulation (Fig. 2C). In these experiments,
quercetin alone did not affect any of these parameters (Figs. 2A, B
and C).3.3. Downregulation of insulin-induced glucose uptake and AKT
serine phosphorylation by TNFa are prevented by quercetin
Insulin-stimulated 2-DG uptake in L6 myotubes was signiﬁ-
cantly reduced by the addition of TNFa (to 33.4% of insulin-
stimulated CTL values). Quercetin, when added prior to TNFa,
prevented the decrease in insulin-stimulated 2-DG uptake. In fact,
insulin-stimulated 2-DG uptake in cells treated with quercetin
combined or not with palmitate was approximately 200% higher
than that of CTL cells. Thus, in these experiments, quercetin itself
was able to increase insulin-stimulated 2-DG uptake irrespective
of the presence of TNFa (Fig. 3A). Insulin-stimulated AKT serine
phosphorylation was reduced by TNFa (to 37.4% of insulin-
stimulated CTL values), and quercetin avoided this reduction
(Fig. 3B).* #&
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Fig. 3. Quercetin prevents downregulation of insulin-induced glucose uptake and
Akt serine phosphorylation elicited by TNFa. L6 myotubes were treated with
25 mM quercetin and/or TNFa (20 ng/ml) as described in the section 2.3. After
treatment, myotubes were incubated in Krebs buffer and acutely (10 min.)
stimulated with insulin (100 nM) or vehicle (NaCl 0.9%). Non-stimulated and
insulin-stimulated L6 myotubes were processed for 2-DG uptake assay (A) and
Western blot detection of serine 473 phosphorylated Akt1/2/3, which was
normalized to b actin (B). Data are presented as mean7S.E.M.. *Po0.05 vs. non
insulin-stimulated myotubes within the same condition; # Po0.05 vs. insulin-
stimulated CTL; & Po0.05 vs. insulin-stimulated TNFa (n¼5 for 2-DG uptake and
phospho Akt).3.4. Quercetin treatment modulates the expression of TNFa and
iNOS in muscle
Quercetin reduced TNFa mRNA levels in muscle of ob/ob mice
(to 48% of CTL mice values) (Fig. 4A). Similarly, quercetin reduced
iNOS expression in muscle of ob/ob mice (to 57% of CTL mice
values) (Fig. 4B). In L6 myotubes, palmitate increased TNFa
expression (to 192.3% of CTL values), and quercetin (5 and
25 mM) suppressed this upregulation. Higher doses of quercetin,
such as 100 and 200 mM, failed to avoid this effect of palmitate
(Fig. 4C). Similarly, palmitate stimulated iNOS expression in L6
myotubes (to 189% of CTL values), and quercetin (25 mM) abol-
ished this effect. Lower (5 mM) and higher (100 and 200 mM)
doses of quercetin also failed to modulate the effect of palmitate
on iNOS expression (Fig. 4D).
3.5. Quercetin treatment decreases JNK but not IkK phosphorylation
in muscle cells
Treatment with quercetin decreased JNK phosphorylation in
skeletal muscle of ob/ob mice (to 53% of CTL mice values) (Fig. 5B)
but did not change IkK phosphorylation (Fig. 5C). JNK phosphor-
ylation was also stimulated in L6 myotubes treated with palmi-
tate for 6 h (to 225% of CTL values), and quercetin suppressed this
effect (Fig. 5D). IkK phosphorylation was not modulated in L6
myotubes treated with palmitate and/or quercetin (Fig. 5F). L6
myotubes treated with TNFa also displayed an increase in JNK
phosphorylation (to 168% of CTL values) which was abolished by
quercetin (Fig. 5E). TNFa increased IkK phosphorylation in L6
myotubes (to 202% of CTL values) which was not modulated by
quercetin (Fig. 5G).
3.6. Quercetin modulates nuclear accumulation of NF-kB and NF-kB
p50 binding to GLUT4 promoter in skeletal muscle cells
Palmitate-induced nuclear p50 accumulation in L6 myotubes
(to 152% of CTL values) was abolished by quercetin (Fig. 6A).
Palmitate has also stimulated c-Rel accumulation in the nucleus
(to 585% of CTL values), which was suppressed by quercetin
(Fig. 6B). Palmitate-induced nuclear p52 accumulation (to 277% of
untreated myotubes values) was not altered by quercetin
(Fig. 6C). We have also found that ob/ob mice treated with
quercetin had reduced NF-kB p50 binding to GLUT4 promoter in
skeletal muscle (to 12% of CTL mice values) (Fig. 6D).4. Discussion
It has been a consensus that quercetin decreases glycemia in
streptozotocin-diabetic rats (Coskun et al., 2005; Vessal et al.
2003); however, since this ﬂavonoid has a protective effect in
pancreatic b-cell (Coskun et al., 2005; Kim et al., 2007), that may
be a result of decreased severity of diabetic condition. The present
study shows that intraperitoneal treatment of ob/ob mice with
quercetin reduces whole-body insulin resistance by acting in
skeletal muscle. A previous study showed that orally given
quercetin improved insulin sensitivity in Zucker rats (Rivera
et al., 2008), although two groups have demonstrated that
quercetin, when mixed with a high-fat diet or when given by
gavage did not ameliorate insulin resistance (Romero et al., 2010;
Stewart et al., 2009). Failure to detect a consistent effect of
quercetin when orally administrated might probably result from
its low intestinal absorption (Nait Chabane et al., 2009) and to its
high metabolization by the enterocytes (Rechner et al., 2002).
This way, only 5.3% of the quercetin orally administrated reaches
blood stream in its original form (Rechner et al., 2002). Thus, our
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resistance, mainly by routes that bypass the gut barriers. In order
to clarify the mechanism by which quercetin improves insulin
sensitivity, we next moved on to experiments with skeletal
muscles of obese mice and with L6 myotubes. Importantly, the
dose of quercetin used in our in vivo experiments was very
similar to those used to describe the effect of quercetin in
streptozotocin-diabetic rats (Dias et al., 2005; Coskun et al.,
2005; Vessal et al. 2003).
Skeletal muscle was chosen as a putative target for quercetin
because glucose uptake by this tissue accounts for the majority of
glucose disposal in the post-prandial period, as well as after a
challenge with exogenous insulin. As the glucose transporter
GLUT4 is the limiting step for glucose uptake (Wallberg-
Henriksson and Zierath, 2001), we initially investigated the
GLUT4 expression in skeletal muscle of obese mice. We have
found that quercetin increased GLUT4 content in skeletal muscle
of ob/ob mice after 10 weeks of treatment, favoring the hypoth-
esis that quercetin action in skeletal muscle might account for the
increase in whole body insulin sensitivity.
To investigate the mechanism of action of quercetin in skeletal
muscle, we next used L6 myotubes challenged with palmitate or
TNFa, very well known to be inducers of insulin resistance in vitro
(Steinberg et al., 2006). At this point, it is important to stress the
differences between the effects of quercetin in L6 myotubes
treated with palmitate or TNFa. Quercetin was able to increase
the levels of 2-DG uptake in myotubes treated with palmitate;
however, cells treated with quercetin plus palmitate did not
recover insulin sensitivity. In contrast, when TNFa was used to
induce insulin resistance, quercetin restored insulin sensitivity.These differences are in accordance with our ﬁndings of AKT
phosphorylation. In these experiments, we found that the impair-
ment of insulin-stimulated AKT phosphorylation by TNFa was
completely avoided by quercetin, which was not seen in palmitate-
treated cells. Thus, restoration of insulin-induced AKT phosphoryla-
tion in TNFa-treated cells might explain the ability of quercetin to
recover insulin-sensitivity, as assessed by 2-DG uptake. The increase
in 2-DG uptake levels (whether basal or insulin-stimulated) induced
by quercetin in palmitate-treated cells is, therefore, likely to result
from a restoration of GLUT4 levels. Although a previous study has
shown that quercetin increases insulin-induced glucose uptake by
adipocytes (Fang et al., 2008), the present study is the ﬁrst to
experimentally evidence that quercetin facilitates insulin action in
skeletal muscle and to relate this action to a modulation of GLUT4
expression.
Another important observation refers to the action of querce-
tin over 2-DG uptake in the absence of palmitate and TNFa.
Quercetin itself did not modulate 2-DG uptake in the experiments
using palmitate to induce insulin resistance, however, in the
experiments that we used TNFa, the sole presence of quercetin
increased 2-DG uptake. This difference might be due to the medium
used in each experiment. Palmitate treatment requires a serum-free
medium with 1% BSA, which was used in all experimental groups. In
the case of experiments using TNFa, all cells were treated with
medium containing 10% FBS. Thus, it is possible that quercetin
synergizes with some serum component to increase 2-DG uptake.
This can be concluded because quercetin by itself, when used in
serum-free medium, did not increased 2-DG uptake.
The reason why quercetin overcomes TNFa- but not palmitate-
induced insulin resistance in muscle might be due to the different
pJNK
A
rb
itr
ar
y 
U
ni
ts
A
rb
itr
ar
y 
U
ni
ts
pJNK
pIκK
pIκK
βactin
β actin
A
rb
itr
ar
y 
U
ni
ts
*
** **
**
**
pJNK pIνK
CT
L
Qu
erCT
L
Qu
er
CT
L
TN
Fα Q2
5
Q2
5 T
NF
α
CT
L Pa
l
Q2
5
Q2
5 P
al
CT
L
TN
Fα Q2
5
Q2
5 T
NF
α
CT
L Pa
l
Q2
5
Q2
5 P
al
A
rb
itr
ar
y 
U
ni
ts
A
rb
itr
ar
y 
U
ni
ts
A
rb
itr
ar
y 
U
ni
ts
Fig. 5. Quercetin modulates the phosphorylation of JNK but not IkK in skeletal muscle
of ob/ob mice and in L6 myotubes treated with palmitate and TNFa. Obese ob/ob mice
were treated either with quercetin (Quer) or vehicle (CTL). At the end of week 10 of
treatment, mice were sacriﬁced and gastrocnemius muscles were used toWestern blot
detection of pJNK, pIkK and b actin (A). Values of pJNK (B) and pIkK (C) were
normalized to those of b actin. L6 myotubes were treated with quercetin 25 mM (Q25)
and/or palmitate (Pal) as described in Section 2.3. After treatment, cells were processed
for Western blot detection of pJNK (D) and pIkK (F) which were normalized to b actin.
L6 myotubes were also treated with quercetin (Q25) and or TNFa as described in the
section 2.3. After treatment, cells were processed for Western blot detection of pJNK
(E) and pIkK (G) which were normalized to b actin. Data are presented as mean7-
S.E.M.. * Po0.05 vs. CTL mice; ** Po0.05 vs. CTL myotubes (n¼4).
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Fig. 6. Quercetin modulates the nuclear accumulation of NF-kB proteins in L6
myotubes treated with palmitate and NF-kB binding to GLUT4 promoter in
skeletal muscle of ob/ob mice L6 myotubes were treated with 25 mM quercetin
(Q25) and/or palmitate (Pal) as described in Section 2.3. After treatment, protein
from nuclear fraction was extracted and subjected to Western blot detection of
p50 (A), cRel (B) and p52 (C). Obese ob/ob mice were treated either with quercetin
(Quer) or vehicle (CTL) and their gastrocnemius muscles were removed and
processed for ChIP assay using anti- NF-kB p50 antibody. Samples were subjected
to real time PCR analysis of GLUT4 promoter and each sample was normalized to
the respective input. The products were run on an agarose gel. The line are as
follows: A-representative input from CTL mice; B-representative input from Quer
mice; C-representative ChIP from CTL mice; D-representative ChIP from Quer
mice; E-100 bp ladder; F-no-AB (D). Data are presented as mean7S.E.M.
* Po0.05 vs. CTL myotubes; ** Po0.01 vs. CTL mice (n¼6 for nuclear extracts
and n¼4 for ChIP assay).
G.F Anheˆ et al. / European Journal of Pharmacology 689 (2012) 285–293 291mechanisms by which these agents induce insulin resistance.
TNFa is widely known to stimulate insulin resistance by activat-
ing JNK (Aguirre et al., 2000). Concordantly, we found thatquercetin efﬁciently abrogated TNFa- and palmitate-induced
JNK phosphorylation. However, palmitate-induced insulin resis-
tance is likely to result from additional metabolic mechanisms
such as ceramides generation, which are known to reduce AKT
activation (Sabin et al., 2007). These additional effects of palmi-
tate leading to insulin resistance are probably not being modu-
lated by quercetin in skeletal muscle cells.
Insulin resistance in obese models is believed to result from
the increased circulating or local production of inﬂammatory
cytokines, as well as from the increased circulating or local
accumulation of saturated free fatty acids (FFA) (Plomgaard
et al., 2005; Thrush et al., 2008). In addition, FFA might exert a
cooperating effect by increasing the expression of inﬂammatory
cytokines such as TNFa, and iNOS in skeletal muscle (Jove´ et al.,
2006). Nitric oxide (NO) resultant from iNOS activity has been
G.F Anheˆ et al. / European Journal of Pharmacology 689 (2012) 285–293292described to induce S-nitrosation of IRS1, thus blunting tyrosine
phosphorylation (Carvalho-Filho et al., 2005). Here, we further
demonstrate that quercetin reduces TNFa and iNOS expression in
skeletal muscle of ob/ob mice after 10 weeks of treatment. This
was also found in palmitate-treated myotubes. These results are
in agreement with a previous report demonstrating that quercetin
reduces circulating TNFa and iNOS expression in adipose tissue of
Zucker rats (Rivera et al., 2008).
It is important to emphasize that the ability of quercetin in
decrease palmitate-stimulated TNFa and iNOS expression was
restricted to doses lower than 100 mM. These ﬁndings are in
accordance with studies describing that an anti-inﬂammatory action
of quercetin comprises doses ranging from 10 to 40 mM. These
moderate concentrations of quercetin are able to inhibit TNFa and
iNOS expression and NF-kB activity in several cell types. In spite of
this, several studies demonstrate that higher doses (above 100 mM)
of this ﬂavonoid stimulate apoptosis in several cancer cell types.
This effect of quercetin is mediated by the generation of Reactive
Oxygen Species (ROS) and inactivation of AKT. Thus, in accordance
with published data, our results show that higher doses of quercetin,
combined with palmitate, are predominantly oxidative/inﬂamma-
tory (increasing TNFa and iNOS expression in L6 myotubes)
(Granado-Serrano et al., 2006; Senthilkumar et al., 2010).
Apart from inhibiting insulin signaling, the inﬂammatory
response elicited by palmitate and TNFamight also induce insulin
resistance by reducing GLUT4 expression in muscle and adipose
cells through NF-kB activation (Furuya et al., 2010; Jove´ et al.,
2006; Silva et al., 2005; Ruan et al., 2002). Accordingly, a recent
report has demonstrated that whole body NF-kB p50 deletion
increases insulin sensitivity by upregulating insulin action in
both liver and skeletal muscle (Gao et al., 2009). According to
these studies, we now show that quercetin is able to recover
GLUT4 expression abrogated by palmitate, and to suppress
palmitate-induced NF-kB accumulation in the nucleus. Besides,
we demonstrate that quercetin reduces the in vivo binding of
NF-kB p50 to GLUT4 promoter in skeletal muscle of ob/ob mice.
Together, these data suggest that the anti-inﬂammatory action of
quercetin, hallmarked by a reduction in NF-kB activity, is related
to the improvement of GLUT4 expression in muscle cells.
In order to focus on the mechanism by which quercetin
modulates NF-kB activity, we assessed IkK phosphorylation.
Under non-stimulated conditions, NF-kB is inactive in the
cytoplasm bound to its inhibitory protein inhibitor of NF-kB
(IkB). Following stimulus, a signaling cascade is triggered result-
ing in the activation of IkK. This kinase leads to phosphorylation
and degradation of the IkB, releasing NF-kB to the nucleus
(Gilmore, 1999). The mechanism by which quercetin downregu-
lates NF-kB nuclear translocation and binding activity in muscle
cells, however, does not seem to involve a reduction in IkK
phosphorylation. Importantly, inhibitory effect of quercetin over
NF-kB has already been described to occur through decreased IkB
degradation (Ying et al., 2009).
The present results demonstrate that intraperitoneal quercetin
treatment improves insulin sensitivity in ob/ob obese mice.
Considering the data presented herein, it is reasonable to
hypothesize that the downregulation of both JNK and NF-kB by
quercetin might act synergistically in skeletal muscle to reduce
palmitate and TNFa action increasing whole-body insulin sensi-
tivity. Favoring this hypothesis, both JNK and NF-kB inhibition
have been described to mediate the anti-inﬂammatory properties
of other ﬂavonoids such as resverastrol (Kundu and Surh, 2004).
Quercetin suppression of NF-kB activation and, by extension,
binding to the GLUT4 promoter is probably involved in the
upregulation of GLUT4 expression. These results point out the
potential role of quercetin for the development of new therapeu-
tic approaches to manage insulin resistance.Acknowledgements
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